These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 34216267)

  • 1. Recent advances in rotavirus reverse genetics and its utilization in basic research and vaccine development.
    Uprety T; Wang D; Li F
    Arch Virol; 2021 Sep; 166(9):2369-2386. PubMed ID: 34216267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus.
    Kanai Y; Onishi M; Kawagishi T; Pannacha P; Nurdin JA; Nouda R; Yamasaki M; Lusiany T; Khamrin P; Okitsu S; Hayakawa S; Ebina H; Ushijima H; Kobayashi T
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33087468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of plasmid only based reverse genetics of rotavirus for the development of next-generation vaccines.
    Desselberger U
    Curr Opin Virol; 2020 Oct; 44():1-6. PubMed ID: 32526696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus reverse genetics systems: Development and application.
    Kanai Y; Kobayashi T
    Virus Res; 2021 Apr; 295():198296. PubMed ID: 33440223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Recombinant Rotaviruses Expressing Fluorescent Proteins by Using an Optimized Reverse Genetics System.
    Komoto S; Fukuda S; Ide T; Ito N; Sugiyama M; Yoshikawa T; Murata T; Taniguchi K
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
    Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ
    Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of rotavirus vaccines.
    Wang CM; Chen SC; Chen KT
    World J Pediatr; 2015 Nov; 11(4):300-8. PubMed ID: 26454434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus vaccines and vaccination in Latin America.
    Linhares AC; Bresee JS
    Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of Recombinant Rotaviruses by Reverse Genetics.
    Agbemabiese CA; Philip AA; Patton JT
    Methods Mol Biol; 2024; 2733():249-263. PubMed ID: 38064037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Double- and Triple-Gene Reassortant G1P[8] Rotaviruses Possessing a DS-1-Like Backbone after Rotavirus Vaccine Introduction in Malawi.
    Jere KC; Chaguza C; Bar-Zeev N; Lowe J; Peno C; Kumwenda B; Nakagomi O; Tate JE; Parashar UD; Heyderman RS; French N; Cunliffe NA; Iturriza-Gomara M
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress in rotavirus VP4 subunit vaccine].
    Jia L; Li T; Ge S
    Sheng Wu Gong Cheng Xue Bao; 2017 Jul; 33(7):1075-1084. PubMed ID: 28869727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse genetics system for human rotaviruses.
    Komoto S; Fukuda S; Murata T; Taniguchi K
    Microbiol Immunol; 2020 Jun; 64(6):401-406. PubMed ID: 32293752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upsurge and spread of G3 rotaviruses in Eastern India (2014-2016): Full genome analyses reveals heterogeneity within Wa-like genomic constellation.
    Banerjee A; Lo M; Indwar P; Deb AK; Das S; Manna B; Dutta S; Bhadra UK; Bhattacharya M; Okamoto K; Chawla-Sarkar M
    Infect Genet Evol; 2018 Sep; 63():158-174. PubMed ID: 29842980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotaviruses and rotavirus vaccines.
    Desselberger U; Manktelow E; Li W; Cheung W; Iturriza-Gómara M; Gray J
    Br Med Bull; 2009; 90():37-51. PubMed ID: 19233929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of rotavirus vaccines in developing countries].
    Delacour H
    Med Trop (Mars); 2009 Aug; 69(4):327-32. PubMed ID: 19725379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Optimized Reverse Genetics System Suitable for Efficient Recovery of Simian, Human, and Murine-Like Rotaviruses.
    Sánchez-Tacuba L; Feng N; Meade NJ; Mellits KH; Jaïs PH; Yasukawa LL; Resch TK; Jiang B; López S; Ding S; Greenberg HB
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32759316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
    Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus vaccines: an update.
    Dennehy PH
    Curr Opin Pediatr; 2005 Feb; 17(1):88-92. PubMed ID: 15659970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Rotavirus Reverse Genetics Systems to Study Viral Replication and Pathogenesis.
    Komoto S; Fukuda S; Murata T; Taniguchi K
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.